Search Within

Cyrus Hedvat

Formats
  1. Meeting Abstract (63)
  2. Journal Article (60)
  3. Conference Paper (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (79)
  2. Hematologic Malignancies, Division of (61)
  3. Department of Pathology and Laboratory Medicine (55)
  4. Center for Hematologic Malignancies (43)
  5. GSK Faculty (34)
  6. Human Oncology and Pathogenesis Program (26)

More Groups

People
  1. Julie Feldstein (33)
  2. Stephen Nimer (20)
  3. Daniel Filippa (17)
  4. David Klimstra (15)
  5. Khedoudja Nafa (15)
  6. Maria Arcila (13)

More People

Years
  1. 2016 (1)
  2. 2014 (8)
  3. 2013 (14)
  4. 2012 (17)
  5. 2011 (14)
  6. 2010 (11)

More Years

Publications
  1. Blood (21)
  2. Journal of Molecular Diagnostics (15)
  3. Modern Pathology (13)
  4. Laboratory Investigation (11)
  5. Cancer Research (6)
  6. American Journal of Surgical Pathology (3)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. Nature Publishing Group (18)
  3. Elsevier Science, Inc. (16)
  4. Nature Research (13)
  5. American Association for Cancer Research (9)
  6. Elsevier Inc. (7)

More Publishers

Results (126)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Expression of p63 in diffuse large B-cell lymphoma
    Journal Article

    Hedvat, C. V.; Teruya-Feldstein, J.; Puig, P.; Capodieci, P.; Dudas, M.; Pica, N.; Qin, J.; Cordon-Cardo, C.; Di Como, C. J.
    Applied Immunohistochemistry & Molecular Morphology (2005)

    Fulltext@MSK | Save
  • Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
    Journal Article

    Gupta, S.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Reich, L.; Costello, S.; Drake, L.; Klimek, V.; Dhodapkar, M.; Teruya-Feldstein, J.; more...
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray
    Journal Article

    Chitale, D. A.; Jungbluth, A. A.; Marshall, D. S.; Leitao, M. M.; Hedvat, C. V.; Kolb, D.; Spagnoli, G. C.; Iversen, K.; Soslow, R. A.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Prospective evaluation of the utility of the serum free light chain assay (FLC), clonal Ig V(L) gene identification and troponin I levels in a phase II trial of risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis
    Conference Paper

    Comenzo, R. L.; Zhou, P.; Reich, L.; Costello, S.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    CRC Press (2004)

    Fulltext@MSK | Save
  • Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial
    Conference Paper

    Comenzo, R. L.; Zhou, P.; Reich, L.; Costello, S.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    CRC Press (2004)

    Fulltext@MSK | Save
  • MEF regulates the growth of ovarian cancer cells
    Meeting Abstract

    Yao, J.; Hedvat, C. V.; Nimer, S. D.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL): Interim results of a phase II study
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells
    Journal Article

    Hedvat, C. V.; Yao, J.; Sokolic, R. A.; Nimer, S. D.
    Journal of Biological Chemistry (2004)

    Fulltext@MSK | Save